Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8784962 | 0.80 | CYP19A1 (0.57) | HTR1AHTR2CCYP19A1POLBRAB9A | |
| SCHEMBL4833706 | 0.77 | CYP11B1 (0.41) | HTR1AHTR2CCYP19A1S1PR1HRH3 | |
| SCHEMBL2351887 | 0.77 | CYP19A1 (0.64) | CYP19A1 | |
| SCHEMBL10288500 | 0.76 | CYP19A1 (0.47) | CYP19A1HRH3RAB9AL3MBTL1 | |
| SCHEMBL15542865 | 0.73 | ALDH1A1 (0.47) | RAB9AL3MBTL1 | |
| SCHEMBL4834371 | 0.70 | CYP19A1 (0.48) | CYP19A1POLBRAB9AL3MBTL1 | |
| SCHEMBL15542806 | 0.68 | CYP11B1 (0.46) | HTR1AHTR2CPOLBL3MBTL1 | |
| SCHEMBL272489 | 0.67 | BRS3 (0.32) | CYP19A1 | |
| SCHEMBL2222933 | 0.67 | CYP19A1 (0.41) | CYP19A1POLB | |
| SCHEMBL1571252 | 0.65 | CYP19A1 (0.67) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011004017-A1 | 1-(6 MEMBERS AZO-HETEROCYCLIC)-PYRROLIN-2-ONE COMPOUNDS AS INHIBITORS OF HEPATITIS C NS5B POLYMERASE, THE PHARMACEUTICAL COMPOSITION THEREOF AND THEIR THERAPEUTIC USE | VIVALIS (FR) | 2011-01-13 | — | — | WO | disclosed |